Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF) (IFIGENIA)

This study has been completed.
Information provided by (Responsible Party):
Zambon SpA Identifier:
First received: March 13, 2008
Last updated: March 4, 2015
Last verified: March 2008